Thanks to Boehringer Ingelheim and BioCT for sponsoring the recent #AISummit. We are pleased that our VP of AI Drug Discovery, Friso Postma, joined a distinguished panel in sharing important insights about the impact of AI on pharma R&D.
BioXcel Therapeutics, Inc.
生物技术
New Haven，Connecticut 9,465 位关注者
Developing transformative medicines in neuroscience using artificial intelligence approaches
关于我们
Biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence
- 网站
-
https://www.bioxceltherapeutics.com
BioXcel Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- New Haven，Connecticut
- 类型
- 上市公司
- 创立
- 2017
- 领域
- Pharmaceutical、Clinical Research、R&D、Scientific、Clinical Pharmacology、Clinical Trials、Big Data、Innovative Medicine、Drug Discovery、Neuroscience、Immuno-oncology和Artificial Intelligence
地点
-
主要
获取路线
555 Long Wharf Dr
12th floor
US，Connecticut，New Haven，06511
BioXcel Therapeutics, Inc.员工
动态
-
Proud to announce that Friso Postma, our VP of AI Drug Discovery, will be speaking on a panel at Boehringer Ingelheim and BioCT’s #AISummit to discuss innovative applications of AI across research and development. Join us! https://lu.ma/oijbjl9r #AI #ResearchandDevelopment
-
-
We have just announced our Q3 2024 earnings. Learn more.??https://bit.ly/3YQUaVj
-
-
We are pleased to have advanced our pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer’s dementia. Learn more.?https://bit.ly/3AskPzB
-
-
We'll be reporting our third quarter 2024 financial results on November 14, 2024. Learn more. https://bit.ly/4fg5WQ0
-
-
We'll be reporting our third quarter 2024 financial results on November 14, 2024. Learn more. https://bit.ly/4fg5WQ0
-
-
Dusan Kostic, our Head of Medical Affairs, recently presented data on Igalmi? (dexmedetomidine sublingual film) in Boston.?https://bit.ly/3ZDVzg5 Thanks to #psychcongress2024 for the opportunity to participate in this important scientific forum.
-
-
Friso Postma, our VP of AI Drug Discovery, joined industry leaders to discuss Real Use of AI in Pharma: Today and in the Near Future. Thanks to?#BioFuture2024 for the opportunity to participate in this important discussion impacting our industry.
-
-
Friso Postma, our VP of AI Drug Discovery, will be participating in a thought-provoking panel at #BioFuture2024 on Oct. 30 at 11 a.m. He’ll be joining industry leaders to discuss Real Use of AI in Pharma: Today and in the Near Future. Register at?www.BioFuture.com! ?
-
-
We’re excited?to be participating at Psych Congress in Boston. We’ll be presenting data on Igalmi (dexmedetomidine sublingual film). Stop by poster 177 Oct. 31 & Nov. 1 from 1:30-3 p.m. to learn more.??https://bit.ly/3ZDVzg5
-